by Isabella Grabski figures by Jovana Andrejevic Clinical trials are critical to study the safety and effectiveness of new drugs, but they are no small endeavor. The cost of a clinical trial can range anywhere from $7 million to over $50 million, and they can take up to a decade to fully complete. Not only can this represent a substantial strain on a pharmaceutical company, it also … Continue reading Virtual Clinical Trials: Testing new drugs from afar
With peanuts being the most common children’s food allergen and the rising prevalence of allergies, discovering a cure for peanut allergies is crucial. Symptoms of an allergic reaction – such as anaphylaxis, leading to the inability to breathe – can be life-threatening and occur rapidly. While EpiPens are used to control general allergic reactions, there is no specific treatment available for peanut allergies – until … Continue reading A cure for peanut allergies in sight?
Multiple sclerosis (MS) is a neurological disease that affects over 2 million people worldwide. In patients who suffer from MS, an abnormal immune response causes damage to a fatty substance called myelin. Like the coating around an electrical wire, myelin insulates nerve cells and facilitates neural communication. Symptoms of MS include muscle weakness, fatigue, and impaired speech. On March 28th 2017, the FDA approved Ocrevus, an … Continue reading FDA Approves New Drug for Multiple Sclerosis
Update: Since the writing of this article, Donald Trump has picked Scott Gottleib as FDA commissioner. -SITN editorial staff by Linda Honaker figures by Rebecca Clements Donald Trump will soon pick a new commissioner for the Federal Drug Administration (FDA). The choice will likely be someone who will try to make the administration’s drug approval requirements less rigorous in order to get drugs on the … Continue reading Make the FDA Great Again? Trump and the future of the drug approval process